The Relationship between Diabetes and Cancers and Its Underlying Mechanisms
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Endocrinology".
Deadline for manuscript submissions: closed (30 May 2022) | Viewed by 5914
Special Issue Editors
Interests: type 1 diabetes mellitus; heart failure; pathogenesis of diabetes; technology in diabetes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Diabetes mellitus and cancer have become public health challenges that have shifted the landscape of disease in recent decades with their swift and continuous increase in prevalence and their significant negative impact on mortality, morbidity, and quality of life. Moreover, the two conditions have been proved to be closely connected—diabetes is associated with a higher risk of several types of cancers such as liver, pancreatic, colon, endometrial, breast, and bladder cancers—and, although the underlying mechanisms remain largely unknown, several risk factors are described to be shared by both diabetes and cancers. Among these, we can identify hormonal, inflammatory, or metabolic parameters of type 2 diabetes, including insulin resistance, obesity and overweight, metabolic syndrome, physical inactivity, and various dietary patterns, while also multiple antidiabetic drugs have been associated with an impact on the incidence of cancers.
Given the fact that many questions relating to the interrelation between these two noncommunicable diseases, with paramount importance assigned to modern medicine, remain unanswered, Medicina is launching a Special Issue entitled “The Relationship Between Diabetes and Cancers and Its Underlying Mechanisms”, aiming to set the stage for an evidence-based, comprehensive, and up-to-date collection of information about this topic. We are kindly inviting you and your collaborators to submit your original research or review articles addressing the pathophysiology, clinical impact, or management regarding the inauspicious association between diabetes mellitus and cancers in an effort to minimize the existing gaps in knowledge and to improve patients’ outcomes.
Prof. Dr. Bogdan Timar
Prof. Dr. Serban Negru
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes mellitus
- cancer
- insulin resistance
- obesity
- metabolic syndrome
- inflammation
- carcinogenesis
